In a joint release of data, a group of researchers hypothesized that a certain stem cell traveling in the bloodstream known as the endothelial progenitor cell could be a vital component in sustaining a healthful and prolonged life. Subsequent information from scientists displayed that when using a specific health supplement called Stem-Kine, the numbers of cells in circulation actually increased.
This study data was published under the title – Circulating Endothelial Progenitor Cells: A New Approach To Anti Aging Medicine? – produced a novel study into the age associated deterioration of mental, cardiovascular and sexual mechanics of action. A universal trait of these situations is a reduction in the circulating endothelial progenitor cells and the capability they have in healing any damage that happens to the inside layer of the blood vessels.
There have been much data printed concerning the many trials and investigations into the significance of these cells and their ability to repair the body’s organs, according to one of the authors of the latest study. Nevertheless, he stated that this is the initial complex rendering in any clinical research peer journals regarding its application to the topic of aging.
The data continues with a description of potential interventions for the maintenance of the amounts of circulating endothelial cells and the reversal of age related deterioration. Of specific importance was the new information demonstrated by the Stem-Kine, a commercial supplement and how it increased by twofold the quantity of circulating endothelial progenitor cells in participants who were healthy after a two week time frame.
The authors of the study were from the University of Utah, Indiana University, University of California at San Diego, The Bio-Communications research Institute, The Center from Improvement of Human Functioning International, Biotheryx, and The Dove Clinic for Integrative Medicine, Novomedix Inc., Medistem Inc. and Aiden Products, all were contributors to the combined publication regarding anti aging medication. More and more there is a cooperative approach to clinical exploration where companies can pool their knowledge and resources for the greater good and of course a furthering of scientific investigation.
One of the participants to the investigation was Medistem Inc., a biotech company that was created to produce and commercially distribute adult stem cell technology in the area of extraction, modification and their use as a treatment for inflammatory and degenerative illnesses. Medistems principal product is the endometrial regenerative cell [ERC], which is a general donor stem cell that was created for critical limb ischemia when a lack of blood is a serious issue.
Tue, Jan 5, 2010
Anti Aging, Anti Aging Theories, Bioscience, Stem cells